Beschreibung
PhoenixDx® SARS-CoV-2 P681R Multiplex is a real-time RT-PCR-based diagnostic test for the in vitro qualitative detection and discrimination of SARS-CoV-2 and the P681R mutants in respiratory specimens and sera from patients who meet COVID-19 clinical and/or epidemiological criteria.
PhoenixDx® SARS-CoV-2 P681R Multiplex detects a target sequence highly specific for SARS-CoV-2 (N gene), mutant P681R SARS-CoV-2 (S gene), wildtype 681P SARS-CoV-2 (S Gene) and one sequence specific for human RNA (RNAse P) serving as a human extraction control (HEC). Additionally, three non-infectious target positive controls (TPC) are included. The positive controls are used to confirm functionality of the assays and overall PCR performance, the human extraction control is used to evaluate the quality of the RNA isolation independently from the SARS-CoV-2 assays in a different detection channel.
Using PhoenixDx® SARS-CoV-2 P681R Multiplex for simultaneous detection and mutant screening is a resource-friendly testing option that saves time and handling steps especially when processing a high sample throughput. SARS-CoV-2 and the P681R mutant are detected in different detection channels allowing for easy and fast analysis at a glance. A human control sequence detected in the Cy5 channel provides means for quality control.
Example Results
Download MSDS here